p53, Bcl-2 and C-Myc expressions in colorectal carcinoma associated with schistosomiasis in Egypt

Cellular Oncology

Volumn 27, Issue 4, 2005, Pages 245-253

  Zalata, Khaled R ^a   Nasif, Wesam A ^b   Ming, Si Chun ^c   Lotfy, Mahmoud ^b   Nada A, Nadia A ^a   El Hak, Nabil Gad ^d   Leech, Stephen H ^c  

^a MANSOURA UNIVERSITY   (Egypt)

^b MENOUFIA UNIVERSITY   (Egypt)

^c TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d MANSOURA UNIVERSITY   (Egypt)

Author keywords

Bcl 2; c Myc; Colorectal carcinoma; p53; Schistosoma mansoni

Indexed keywords

MONOCLONAL ANTIBODY; MYC PROTEIN; PROTEIN BCL 2; PROTEIN P53;

ADULT; AGED; APOPTOSIS; ARTICLE; COLORECTAL CARCINOMA; CONTROLLED STUDY; CORRELATION ANALYSIS; EGYPT; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MUCINOUS CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS; SIGNET RING CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; APOPTOSIS; COLORECTAL NEOPLASMS; EGYPT; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PROTO-ONCOGENE PROTEINS C-BCL-2; PROTO-ONCOGENE PROTEINS C-MYC; SCHISTOSOMIASIS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 30644480496     PISSN: 15705870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. M.F. Abdel-Wahab, Schistosomiasis in Egypt, 2nd edn, CRC Press, Cairo, 1986.
2. A.A. Ata, A clinicopathological study of schistosomal colonic polyposis and their pathogenesis, J. Egypt. Med. Assoc. 53 (1970), 762-769.
3. G.B. Baretton, J. Diebold, G. Christoforis, M. Vogt, C. Muller and K. Dopfer, Apoptosis and immunohistochemical Bcl-2 expression in colorectal adenomas and carcinomas. Aspect of carcinogenesis and prognostic significance, Cancer 77 (1996), 255-264.
4. D.M. Barnes, E.A. Dublin, C.J. Fisher, D.A. Levison and R.R. Millis, Immunohistochemical detection of p53 protein in mammary carcinoma: An important new independent indicator of prognosis?, Hum. Pathol. 24 (1993), 496-476.
5. I.O. Bass, J.W.R. Mulder, G.J.A. Offerhaus, B. Vogelstein and S.R. Hamilton, An evaluation of six antibodies for immunohistochemistry of mutant p53 gene product in archival colorectal neoplasms, J. Pathol. 172 (1994), 5-12.
6. J. Batric, J. Bartkova, B. Vojtesek, Z. Staskova, J. Lukas and A. Rejthar, Aberrant expression of the p53 oncoprotein is a common feature of a wide spectrum of human malignancies, Oncogene 6 (1991), 1699-1703.
7. N.R. Bergquist, Schistosomiasis: From risk assessment to control, Trends Parasitol. 18 (2002), 309-314.
8. B.L. Cline, F.O. Richards, M.A. El-Alaway, S. El-Hak, E. Ruiz-Tiben and J.M. Hughes, 1983 Nile Delta schistosomiasis survey: 48 years after Scott, Am. J. Trop. Med. Hyg. 41 (1989), 56-62.
9. A. Costa, R. Marasca, B. Valentinins, M. Savarino, A. Faranda and R. Silvestrini, p53 gene point mutations in relation to p53 nuclear protein accumulation in colorectal cancers, J. Pathol. 176 (1995), 45-53.
10. M.N. El-Bolkainy, General Pathology of Cancer, 1st edn, Al-Asdekaa Graphic Center, Cairo, Egypt, 1991.
11. S.S. El-Din, M.M. Massoud, S. Hossny, I.M. El-Gindy and M.A. Arafa, Histochemical studies on rectal mucosa in active intestinal schistosomiasis, J. Egypt. Soc. Parasitol. 21 (1991), 445-457.
12. A.R. El-Mazney, M.I. Chazaly, M.H. Maamoun and S. Abuzeid, Relation of bilharziasis of the colon and rectum to carcinoma, J. Egypt. Gastroentrology 6 (1972), 81-87.
13. A. El-Roby, The gastroenterology of schistosomiasis in complied review on bilharziasis, The National information and documentation center (NIDOC), Cairo, 1991, pp. 137-143.
14. M.F. Elshal, I.H. Elsayed, I.M. El Kady, G. Badra, A. El-Refaei, M. El-Batanony and O.M. Hendy, Role of concurrent S. mansoni infection in H. pylori-associated gastritis: A flow cytometric DNA-analysis and oxyradicals correlations, Clin. Chim. Acta 346(2) (2004), 191-198.
15. D. Engels, L. Chitsulo, A. Montresor and L. Savioli, The global epidemiological situation of schistosomiasis and newapproaches to control and research, Acta Trop. 82 (2002), 139-146.
16. W. Guo, W. Zheng, J.Y. Li, J.S. Chen and W.J. Blot, Correlation of colon cancer mortality with dietary factors, serum markers, and schistosomiasis in China, Nutr. Cancer 20 (1993), 13-20.
17. P.A. Hall and D.P. Lane, p53 in tumor pathology: Can we trust immunohistochemistry? - Revisited, J. Pathol. 172 (1994), 1-4.
18. R. Hamelin, P. Laarent-Puig, S. Olschwang, N. Jego, B. Asselain and Y. Remvikos, Association of p53 mutations with short survival in colorectal cancer, Gastroenterology 106 (1994), 42-48.
19. M. Hollstein, K. Rice, M.S. Greenblatt, T. Soussi, R. Fuchs and T. Sorlie, Database of p53 gene somatic mutations in human tumors and cell lines, Nucleic Acids Res. 22 (1994), 3551-3555.
20. R.V.P. Hutter and L.H. Sobin, A universal staging system for cancer of the colon and rectum, Arch. Pathol. Lab. Med. 110 (1986), 367-368.
21. J.R. Jass and L.H. Sobin, World Health Organization. International histological classification of tumors, in: Histological Typing of Intestinal Tumors, 2nd edn, Springer-Verlag, Berlin, 1989, pp. 29-35.
22. H. Joensuu, L. Pylkkanen and S. Toikkanen, Bcl-2 protein expression and long-term survival in breast cancer, Am. J. Pathol. 145 (1994), 1191-1198.
23. L. Kaklamanis, K.C. Gatter, N. Mortensen, R.J. Baigrie, A. Heryet and D.P. Lane, p53 Expression in colorectal adenomas, Am. J. Pathol. 142 (1993), 87-93.
24. L. Kaklamanis, A. Savage, N. Mortensen, P. Tsiotos, Doussis- Anagnostopoulou and S. Biddolph, Early expression of Bcl-2 protein in the adenoma-carcinoma sequence of colorectal neoplasia, J. Pathology 179 (1996), 10-14.
25. D.P. Lane, The regulation of p53 function: Steiner award lecture, Int. J. Cancer 57 (1994), 623-627.
26. L. Leoncini, M.T. Delvecchio, T. Megha, P. Barbini, P. Galieni and S. Pileri, Correlations between apototic and proliferative indices in malignant non-Hodgkin's lymphomas, Am. J. Pathol. 142 (1993), 755-763.
27. A.J. Levine, M.E. Perry, A. Chang, A. Silver, D. Dittmer and M. Wu, The 1993 Walter Hubert lecture: The role of p53 tumor suppresser gene in tumorgenesis, Br. J. Cancer 69 (1994), 409-416.
28. Q. Lu, P. Abel, C.S. Foster and E. Lalani, Bcl-2: Role in epithelial differentiation and oncogenesis, Hum. Pathol. 27 (1996), 102-110.
29. C. Ming-Chai, C. Chi-Yuan, C. Pel-Yu and H. Jen-Chun, Evaluation of colorectal cancer in schistosomiasis transitional mucosal changes adjacent to large intestinal carcinoma in colectomy specimens, Cancer 46 (1980), 1661-1675.
30. B.D. Minsky, Clinicopathologic impact of colloid in colorectal carcinoma, Dis. Colon Rectum. 33 (1990), 714-719.
31. A.E. Mohamed, M.A. Al Karawi and M.Y. Yasawy, Schistosomal colonic disease, Gut 31 (1990), 439-442.
32. M.A. Mostafa, S.A. Sheweita and P.J. O'Connor, Relationship between schistosomiasis and bladder cancer, Clinical Microbiology Reviews 12 (1999), 97-111.
33. D. Ofner, K. Riehemann, H. Maier, B. Riedmann, H. Nehoda and M. Totsch, Immunohistochemically detectable Bcl-2 expression in colorectal carcinoma: Correlation with tumor stage and patient survival, Br. J. Cancer 72 (1995), 981-985.
34. D.N. Poller, K.J. Baxter and N.A. Shepherd, p53 and Rb1 protein expression: Are they prognostically useful in colorectal cancer?, Br. J. Cancer 75 (1997), 87-93.
35. J.C. Reed, Bcl-2 and the regulation of programmed cell death, J. Cell. Biol. 124 (1994), 1-6.
36. A.G.P. Ross, P.B. Bartley, A.C. Sleigh, G.R. Olds, Y. Li, G.M. Williams and D.P. McManus, Schistosomiasis (review article), N. Engl. J. Med. 346(16) (2002), 1212-1220.
37. J.A. Royds, M. Sharrard, B. Wagner and S.V. Polacanz, Cellular localization of C-Myc product in human colorectal epithelial neoplasia, J. Pathol. 166 (1992), 225-233.
38. J.C. Sabourin, A. Martin, J. Baruch, J.B. Truc, A. Gompel and P. Poitout, Bcl-2 expression in normal breast tissue during the menstrual cycle, Int. J. Cancer 59 (1994), 1-6.
39. C.E. Sarraf and I.D. Bowen, Proportions of mitotic and apoptotic cells in a range of untreated experimental tumors, Cell Tissue Kinet. 21 (1988), 45-49.
40. N. Scott and P. Quirke, Molecular biology of colorectal neoplasm, Gut 34 (1993), 289-292.
41. K. Shindo, Significance of schistosomiasis japonica in the development of cancer of the large intestine. Report of a case and review of the literature, Dis. Colon. Rectum. 19 (1976), 460-469.
42. K. Sikora, S. Chan, G. Evan, H. Gabra, N. Markham and J. Stewart, C-myc oncogene expression in colorectal cancer, Cancer 59 (1987), 1289-1295.
43. M.F.M. Soliman and N.S. El-Shenawy, Evaluation of the protective effect of two antioxidative agents in mice experimentally infected with Schistosoma mansoni: hematological and histopathological aspects, Pak. J. Biol Sci. 6 (2003), 887-897.
44. J. Stewart, G. Evan, J.V. Watson and K. Sikora, Detection of the C-Myc oncogene product in colonic polyps and carcinomas, Br. J. Cancer 53 (1986), 1-6.
45. C. Walker, L. Robertson, M. Myskow and G. Dixon, Expression of the Bcl-2 protein in normal and dysplastic bronchial epithelium and in lung carcinomas, Br. J. Cancer 72 (1995), 164-169.
46. A.R.W. Williams, J. Piris and A.H. Wyllie, Immunohistochemical demonstration of altered intracellular localization of the C-Myc oncogene product in human colorectal neoplasm, J. Pathol. 160 (1990), 287-293.
47. M. Wu, M. Arsura, R.E. Bellas, M.J. Fitzgerald, H. Lee and S.L. Schauer, Inhibition of C-Myc expression induces apoptosis of WEHI 231 murine B cells, Mol. Cell Biol. 16 (1996), 5015-5025.